-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓ISIN BE0003818359-
Galapagos NVBörse Börse BerlinEURSymbol GXE
-
Galapagos NVBörse Xetra FrankfurtEURSymbol GXE
-
EURGalapagos NVBörse Börse Frankfurt
-
Galapagos NVBörse Börse FrankfurtISIN US36315X1019
-
GALAPAGOS NVBörse Quotrix System der Börse DüsseldorfEURSymbol GXE
-
GALAPAGOS NVBörse Börse MünchenEURSymbol GXE
-
GALAPAGOS NVBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol GXE
-
GALAPAGOS NVBörse Gettex System der Börse MünchenEURSymbol GXE
-
GALAPAGOS NVBörse Börse DüsseldorfEURSymbol GXE
-
GALAPAGOS NVBörse Börse StuttgartEURSymbol GXE
-
ISIN US36315X1019 WKN: A0YGNJUSDSymbol GLPG
-
ISIN BE0003818359 WKN: A0EAT9Symbol GXE
-
EURGalapagos NVBörse Euronext Amsterdam
-
USD
-
ISIN BE0003818359
WKN A0EAT9
Symbol GXE
Firmenname
Galapagos NV
Marktkapitalisierung
4.325.159.008 (+- 28%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
5.535.318.016 oder 3.115.000.000
Mitarbeiter
1.338
KGV
60.65
EBITDA 0
Buchwert 25.493
Galapagos NV outperformed den DAX um +509 % vom 05.05.2014 bis 10.07.2019
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 69,5 USD -3,10%
Entdecke die 6 ETFs in denen Galapagos NV am höchsten gewichtet ist Insgesamt in 13 ETFs enthalten
Dir gefallen die Informationen zu Galapagos NV?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Galapagos NV?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Galapagos NV?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Galapagos NV?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
36 News & Informationen zur Galapagos NV Aktie
Galapagos Says New CEO Will Have Strong Science Background
GuruFocus Article or News written by Barry Cohen and the topic is about: Founder and CEO van de Stope leaving after several R&D misses
Galapagos NV announces retirement of CEO
Galapagos NV (GLPG) announces the planned retirement of CEO Onno van de Stolpe.Onno van de Stolpe co-founded Galapagos in 1999 and built and led the company as CEO from its early R&D…
Deerfield Management Company, L.p. (series C) Buys Singular Genomics Systems Inc, CareMax Inc, AdaptHealth Corp, Sells Boston Scientific Corp, , Biogen Inc
GuruFocus Article or News written by insider and the topic is about:
Susquehanna International Securities, Ltd. Buys Carnival Corp, Plug Power Inc, BP PLC, Sells Nokia Oyj, HSBC Holdings PLC, WPP PLC
GuruFocus Article or News written by insider and the topic is about:
Galapagos Nv (GLPG): Price Now Near $58.86; Daily Chart Shows Downtrend on 100 Day Basis
Galapagos NV (GLPG) CEO Onno van de Stolpe on Q2 2021 Results – Earnings Call Transcript
Galapagos NV (NASDAQ:GLPG) Q2 2021 Earnings Conference Call August 6, 2021 08:00 AM ET Company Participants Sofie Van Gijsel – IR Onno van de Stolpe – CEO Dr.
GILEAD SCIENCES : ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS (Form 8-K)
U.S.
86
90
175
162
… | July 29, 2021
Crohn's Disease Market Set to Observe Remunerative Growth at a CAGR of 7.6% During the Study Period 2018-30
/PRNewswire/ — DelveInsight's Crohn's Disease (CD) Market report offers comprehensive coverage of the current treatment practices, pipeline drugs, Crohn's…
Were Hedge Funds Right About Park Hotels & Resorts Inc. (PK)?
In this article we will analyze whether Park Hotels & Resorts Inc. (NYSE:PK) is a good investment right now by following the lead of some of the best…
Hedge Funds Are Buying Galapagos NV (GLPG)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their…
Galapagos Nv (GLPG): Price Now Near $59.51; Daily Chart Shows Downtrend on 100 Day Basis
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 68 companies hit new 52-week lows.
Points of Interest: TotalEnergies (NYSE:TTE) was the biggest company by market cap to …
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ju…
Here's Why Galapagos Stock Is Falling Today
The company's new salt-inducable kinase inhibitor program is getting off to a rocky start.
Galapagos (GLPG) Falls on Inflammatory Study Data Readout
Galapagos (GLPG) announces data from multiple studies evaluating its two inflammatory candidates – GLPG3970 and GLPG3667. Stock down.
Futures Slide As Yield Drop Accelerates
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
Pre-market Movers: ATHE, HUDI, VERB, SGOC, IMUX…
The following are some of the stocks making big moves in Thursday's pre-market trading (as of 4.43 A.M. EDT)..
Galapagos : demonstrates early clinical activity with SIK2/3 inhibition in inflammation (Form 6-K)
Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation
Biologic effect of salt inducible kinase mechanism in firstpatient studies… | July 14, 2021
Galapagos : reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study (Form 6-K)
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
Generally safe and well tolerated
… | July 14, 2021
Galapagos Demonstrates Early Clinical Activity With SIK2/3 Inhibition In Inflammation
Biologic effect of salt inducible kinase ( SIK ) mechanism in first patient studies supports further progression of Toledo portf olio
SIK2/3
Galapagos Reports Positive Topline Results With Selective TYK2 Inhibitor GLPG3667 In Phase 1b Psoriasis Study
Generally safe and well tolerated
Positive efficacy signal in psoriasis patients at We ek 4
40% of patients showed improvement of at least 50
CIT Group Inc. (CIT) Fell Out Of Favor With Hedge Funds
In this article we will analyze whether CIT Group Inc. (NYSE:CIT) is a good investment right now by following the lead of some of the best investors in…
On an Alaskan island, a mayor fights for fur seals
On an Alaskan island, a mayor fights for fur seals – and a new future
28 Stocks Moving in Friday's Pre-Market Session
Gainers Toughbuilt Industries Inc (NASDAQ:TBLT) shares rose 61% to $1.16 in pre-market trading after the company reported 1H sales through Amazo…
Stocks That Hit 52-Week Lows On Thursday
Thursday morning, 158 companies reached new 52-week lows.
Noteworthy Highlights: The largest company in terms of market cap to set a new …
Explainer: What's at stake in WTO talks on fishing rules? By Reuters
Explainer: What's at stake in WTO talks on fishing rules?
Stocks That Hit 52-Week Lows On Wednesday
Before 10 a.m. ET on Wednesday, 49 companies set new 52-week lows.
Noteworthy Highlights: The largest company in terms of market cap to set a new …
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ju…
Hedge Funds Keep Buying Acadia Healthcare Company Inc (ACHC)
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade. Most investors who decided…
Where Do Hedge Funds Stand On Vontier Corporation (VNT)?
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors…
Galapagos NV Stock Appears To Be Possible Value Trap
GuruFocus Article or News written by GF Value and the topic is about:
Galapagos: It's Not As Bad As Valued By The Market (NASDAQ:GLPG)
Galapagos has over $6.2 billion in cash with no debt and a market capitalization of only $4.5 billion.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday morning, 7 companies reached new 52-week lows.
Interesting Points: AbCellera Biologics (NASDAQ:ABCL) was the largest firm by market …
JPMorgan names ‘extremely cheap’ stocks in a market with room to rise
JPMorgan analysts said a shift towards value continued “have legs” and picked a number of European stocks to take advantage of this trend.
Selvita completes acquisition of Fidelta from Galapagos
/PRNewswire/ — Galapagos NV [Euronext & NASDAQ: GLPG] and Selvita S.A. [WSE: SLV] announced today that the strategic transaction in which Selvita has acquired…
Selvita completes acquisition of Fidelta from Galapagos
Mechelen, Belgium and Krakow, Poland – 04 January 2021, 22.01 TIME CET – Galapagos NV ((Euronext &, NASDAQ:GLPG) and Selvita S.A. (WSE: SLV) …